// App-Quantinova.ai

: Risk for vascular thromboembolic events (VaTEs) in patients (pts) with advanced urinary tract cancer (aUTC) treated with chemotherapy.

Researchers

Presenter

  • Aristotelis Bamias

Principal Investigators

  • George Tsironis

  • Ioannis Dimitriadis

  • Kimon Tzanis

  • Anna Tsiara

  • Aikaterini Xirokosta

  • Maria Kaparelou

  • Anastasios Kyriazoglou

  • Abis Cohen

  • Despoina Barbarousi

  • Konstantinos Koutsoukos

  • Michael Liontos

  • Roubini Zakopoulou

  • Euthymios Kostouros

  • Stamatina Pagoni

  • Charis Matsouka

  • Meletios A. Dimopoulos

Medical Centers

  • Dept. of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece

  • Dept. of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece

  • Dept. of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece

  • Hellenic Genito-Urinary Cancer Group (HGUCG), Athens, Greece

  • Hematology Division, Alexandra General Hospital, Athens, Greece

  • Dept. of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece

  • Third Department of Internal Medicine, General Hospital of Athens "G. Gennimatas", Athens, Greece

Locations

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Genetic Disorder

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Central Nervous System (CNS)

Disease

  • Urinary tract cancers

  • Ischemic stroke

  • Venous thrombosis

  • Solid malignancies

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved